We have opened an investigation into adverse reactions resulting from LUPRON DEPOT,
an endometriosis and prostate cancer drug made by ABBOTT LABS.
If you or a loved one have been exposed to Lupron or other GnRH agonists and have any comments, please
fill out our comments form and refer to the featured news reports below. We would love to hear your story.
After Darcy Spears' investigative news reports regarding LUPRON
DEPOT (featured below) were aired, the FDA issued a formal Safety Announcement about continued evaluation
of GnRH agonists, entitled:
"FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and possible increased risk
of diabetes and certain cardiovascular diseases."
The FDA also issued a recent statement
regarding OSTEOPOENIA & THYROID DISORDER associated with LUPRON DEPOT. For more information
from the FDA, please click below.
